EUROPE BLOOD PLASMA MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

EUROPE BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Application, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the Europe blood plasma market depicts that the market will grow at a stable pace with a CAGR of 6.09% in terms of revenue during the forecast period 2019-2027.

The countries that have been studied in the Europe blood plasma market are:

•    Germany

•    The United Kingdom

•    France

•    Italy

•    Spain

•    Russia

•    Rest of Europe

France is the predominant European blood plasma market due to its favorable reimbursement policies. However, Germany has displayed the fastest growth and has become a prime consumer of blood and blood products. Apart from the regulatory activities performed by the PPTA, EU policies motivate participation in developing novel plasma therapies often by influencing the demand for plasma in various therapies. For example, Commission Communication on Rare Diseases defined a widely applicable approach for improving the visibility of rare diseases throughout Europe. Demand for blood plasma therapies in Europe is significant and requires a steady supply of blood plasma throughout the region. Millions of patients undergo blood component transfusion per year to recover from several chronic diseases.

France is a major contributor to the European blood plasma market with regional market players focusing on maintaining track of France’s plasma supply. For example, LFB worked with Biolog-id to develop an RFID system to automate their process for bar codes that track plasma bags supplied from concerned organizations. LFB receives plasma from the French Blood Agency, which LFB fractionates to separate its various components. LFB Biomédicaments, one of the company's divisions, is the world’s sixth-largest player in the field of plasma-derived medicinal products and the largest in France. The use of RFID technology to ensure appropriate tracking of plasma fractionation in France offers easy traceability solutions for blood plasma suppliers.

Grifols S.A. is an international company manufacturing and supplying protein therapies for patients. The company, headquartered in Barcelona, Spain, also provides medical care tools to hospitals, pharmacies and other healthcare professionals. The three prime divisions of the company are bioscience, diagnostics and hospitals. Grifols provides innovative products, as well as services to medical professionals in more than 90 countries. It is a leading manufacturer of plasma-derived therapies, which are essentially used in the treatment of patients suffering from rare genetic diseases and severe infections. Grifols primarily manufactures diagnostic products, pharmaceutical and plasma products such as proteinase inhibitors, IV immunoglobulins, antihemophilic factor and coagulation factors.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE BLOOD PLASMA MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF RIVALRY

2.3. VENDOR SCORECARD

2.4. CLINICAL GUIDELINES

2.5. REGULATION IN THE PLASMA THERAPEUTICS

2.6. KEY INSIGHTS

2.7. REGULATORY OUTLOOK

2.8. MARKET TRENDS

2.9. MARKET DRIVERS

2.9.1.   EXPANSION IN INDICATION FOR NEW THERAPEUTIC AREAS

2.9.2.   APPROVAL OF IMMUNOGLOBULIN-CENTERED THERAPIES

2.9.3.   SURGE IN THE HEMOPHILIA TREATMENT

2.10.            MARKET RESTRAINTS

2.10.1.                HIGH COSTS OF BLOOD PLASMA TREATMENTS

2.10.2.                EASY AVAILABILITY OF RECOMBINANT PLASMA

2.11.            MARKET OPPORTUNITIES

2.11.1.                INCREASING PUBLIC COGNIZANCE

2.11.2.                RISE IN THE PLASMA-DERIVED PRODUCTS OPPORTUNITIES

2.11.3.                INCREASING OCCURRENCE OF HEMOPHILIA

2.12.            MARKET CHALLENGES

2.12.1.                SPREAD OF PATHOGENIC CONTAMINANTS

2.12.2.                HIGH REGULATIONS IN THE MARKET

2.13.            BLOOD PLASMA INDUSTRY BY MODE OF DELIVERY

2.13.1.                INFUSION SOLUTIONS

2.13.2.                GELS

2.13.3.                SPRAYS

2.13.4.                BIOMEDICAL SEALANTS

3.    BLOOD PLASMA MARKET OUTLOOK - BY BLOOD TYPE

3.1. ALBUMIN

3.2. IMMUNOGLOBULIN

3.2.1.   INTRAVENOUS IMMUNOGLOBULIN

3.2.2.   SUBCUTANEOUS IMMUNOGLOBULIN

3.2.3.   OTHER IMMUNOGLOBULIN TYPE

3.3. COAGULATION FACTOR CONCENTRATES

3.4. HYPERIMMUNES

3.5. OTHER PLASMA FRACTIONATION PRODUCTS

4.    BLOOD PLASMA MARKET OUTLOOK - BY APPLICATION

4.1. ONCOLOGY

4.2. HEMATOLOGY

4.3. TRANSPLANTATION

4.4. RHEUMATOLOGY

4.5. NEUROLOGY

4.6. IMMUNOLOGY

4.7. PULMONOLOGY

4.8. OTHER APPLICATIONS

5.    BLOOD PLASMA MARKET OUTLOOK - BY END-USER

5.1. ACADEMIC INSTITUTIONS

5.2. RESEARCH LABORATORIES

5.3. HOSPITALS AND CLINICS

6.    BLOOD PLASMA MARKET - REGIONAL OUTLOOK

6.1. EUROPE

6.1.1.   COUNTRY ANALYSIS

6.1.1.1.      FRANCE

6.1.1.2.      GERMANY

6.1.1.3.      THE UNITED KINGDOM

6.1.1.4.      ITALY

6.1.1.5.      SPAIN

6.1.1.6.      RUSSIA

6.1.1.7.      REST OF EUROPE

7.    COMPANY PROFILES

7.1. SHIRE PLC

7.2. ARTHREX

7.3. OCTAPHARMA AG

7.4. BAXTER INTERNATIONAL, INC.

7.5. GRIFOLS INTERNATIONAL S.A.

7.6. BIOTEST AG

7.7. CSL LTD.

7.8. ADMA BIOLOGICS, INC.

7.9. CHINA BIOLOGIC PRODUCTS, INC.

7.10.            GENERAL ELECTRIC CO.

7.11.            CERUS CORP.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        EUROPE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

TABLE 2        BLOOD PLASMA COMPONENTS

TABLE 3        EUROPE BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)

TABLE 4        EUROPE BLOOD PLASMA MARKET IN IMMUNOGLOBULIN BY TYPES 2019-2027 ($ MILLION)

TABLE 5        PROTEASE INHIBITORS USED IN THE HIV INFECTION TREATMENT

TABLE 6        EUROPE BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 7        EUROPE BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 8        EUROPE BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)       

List of Figures

FIGURE 1      EUROPE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 2      IMMUNOGLOBULIN INFUSIONS SIDE-EFFECTS

FIGURE 3      ROLE OF FIBRIN SEALANT IN COAGULATION CASCADE

FIGURE 4      EUROPE BLOOD PLASMA MARKET IN ALBUMIN 2019-2027 ($ MILLION)

FIGURE 5      EUROPE BLOOD PLASMA MARKET IN IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 6      EUROPE IMMUNOGLOBULIN MARKET IN INTRAVENOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 7      EUROPE IMMUNOGLOBULIN MARKET IN SUBCUTANEOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 8      EUROPE IMMUNOGLOBULIN MARKET IN OTHER IMMUNOGLOBULIN TYPE 2019-2027 ($ MILLION)

FIGURE 9      EUROPE BLOOD PLASMA MARKET IN COAGULATION FACTOR CONCENTRATES 2019-2027 ($ MILLION)

FIGURE 10   HYPERIMMUNES ISOLATION PROCESS

FIGURE 11   EUROPE BLOOD PLASMA MARKET IN HYPERIMMUNES 2019-2027 ($ MILLION)

FIGURE 12   EUROPE BLOOD PLASMA MARKET IN OTHER PLASMA FRACTIONATION PRODUCTS 2019-2027 ($ MILLION)

FIGURE 13   EUROPE BLOOD PLASMA MARKET IN ONCOLOGY 2019-2027 ($ MILLION)

FIGURE 14   EUROPE BLOOD PLASMA MARKET IN HEMATOLOGY 2019-2027 ($ MILLION)

FIGURE 15   EUROPE BLOOD PLASMA MARKET IN TRANSPLANTATION 2019-2027 ($ MILLION)

FIGURE 16   LUPUS INFECTION SYMPTOMS

FIGURE 17   EUROPE BLOOD PLASMA MARKET IN RHEUMATOLOGY 2019-2027 ($ MILLION)

FIGURE 18   EUROPE BLOOD PLASMA MARKET IN NEUROLOGY 2019-2027 ($ MILLION)

FIGURE 19   EUROPE BLOOD PLASMA MARKET IN PULMONOLOGY 2019-2027 ($ MILLION)

FIGURE 20   EUROPE BLOOD PLASMA MARKET IN IMMUNOLOGY 2019-2027 ($ MILLION)

FIGURE 21   EUROPE BLOOD PLASMA MARKET IN OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 22   EUROPE BLOOD PLASMA MARKET IN ACADEMIC INSTITUTIONS 2019-2027 ($ MILLION)

FIGURE 23   EUROPE BLOOD PLASMA MARKET IN RESEARCH LABORATORIES 2019-2027 ($ MILLION)

FIGURE 24   EUROPE BLOOD PLASMA MARKET IN HOSPITALS AND CLINICS 2019-2027 ($ MILLION)

FIGURE 25   FRANCE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 26   GERMANY BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 27   THE UNITED KINGDOM BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 28   ITALY BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 29   SPAIN BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 30   RUSSIA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 31   REST OF EUROPE BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;